Advertisement for orthosearch.org.uk
Results 1 - 4 of 4
Results per page:
Applied filters
Content I can access

Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 96-B, Issue SUPP_9 | Pages 5 - 5
1 May 2014
Phadnis J Templeton-Ward O Guthrie H
Full Access

Implementation of the World Health Organisation checklists have reduced errors, however, the impact of pre-operative briefings on adverse events has not been assessed. A prospective case control study assessing the association between pre-operative briefings and minor, potentially major and major adverse events was performed in two phases. Phase one involved prospective data collection for trauma and orthopaedic lists over 2 weeks. Changes were implemented and following this, the study was repeated (phase two). 41 lists were audited during phase one and 47 lists in phase two. Adequate pre-operative briefings were performed in 10/41 lists (24%) in phase one. There was a significant association between the occurrences of intra-operative adverse events (n=37) when a briefing was not performed (p=<0.01), and when a briefing was performed incompletely (p=0.01). In phase two, after staff re-education and policy change, briefings were found to be adequate in 38/47 lists (81%) with the occurrence of only three minor adverse events. Team familiarity also improved significantly (p=0.02). Inadequate pre-operative briefings are associated with increased minor adverse events and are detrimental to team familiarity. On the basis of our findings we recommend that all surgical units perform pre-operative briefings.


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXXIX | Pages 196 - 196
1 Sep 2012
Akram T Templeton-Ward O Yousaf S Hargrove R
Full Access

Following the outcomes of the RECORD trials the protocol of extended thromboprophylaxis in patients undergoing elective primary total hip or knee arthroplasty has been changed in our institution.

Between June 2008 and May 2009 patients were offered extended thromboprophylaxis with 150mg of aspirin daily, commencing preoperatively on admission and continuing for a total of six weeks. From June 2009 onwards patients were treated with 10mg of rivaroxaban once daily for two weeks following total knee and five weeks following total hip arthroplasty commencing 4 to 6 hours postoperatively. Our cohorts were 700 patients before and after the introduction of the new regimen. The two groups were matched for age, sex and type of operation. All patients with no contraindication to treatment with aspirin or rivaroxaban respectively undergoing elective primary total hip or knee arthroplasty were included in the study. Patients receiving warfarin on admission were treated with warfarin postoperatively and were excluded.

We have compared the two treatment protocols in terms of safety and efficacy. Results focus on 4 safety outcome measures including mortality, haemorrhagic complications, transfusion requirements and infection rates and 2 efficacy outcome measures including thromboembolic complications and length of inpatient stay.

Rates of DVT were equal in the two cohorts (P< 0.005) as were the mortality rates. Transfusion requirements post-operatively were not affected by the introduction of the new regimen however there was a significant increase in both return to theatre rates and prolonged wound ooze (P< 0.005). Infection rates were slightly higher in the cohort treated with rivaroxaban but this was not statistically significant.

We conclude that further trials need to be done to confirm the suitability of routine use of rivaroxiban.


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXXIX | Pages 125 - 125
1 Sep 2012
Templeton-Ward O Griffiths D Higgs D Falworth M Bayley I Lambert S
Full Access

Reverse polarity total shoulder arthroplasty (RTSA) has gained popularity over recent years for the treatment of the painful cuff deficient shoulder. Although proposed over 20 years ago and despite good clinical outcomes the RTSA has struggled to gain popularity due to reported high levels of complications.

One such complication is post-operative instability with frequencies of up to 30% (De Wilde 2002). The Bayley-Walker RTSA was designed specifically for patients with difficult reconstruction problems in whom an unconstrained prosthesis would not offer sufficient stability. It is a reverse anatomy fixed fulcrum constrained prosthesis. The glenoid component has a long HA-coated tapered helical screw, with large pitch and depth, fixation is augmented by a grooved HA coated glenoid plate.

The purpose of this study was to review the clinical experience from The Royal National Orthopaedic Hospital Stanmore and to ascertain the rate of glenoid component loosening. We also carried out a radiographic review to correlate loosening with patterns of lucency on post-operative radiographs. One hundred and five B-W TSRs in 103 patients were included, 24% of which were performed as revision of previous failed arthroplasty. In total, 8/105 glenoids required revision. Of those eight patients, two were cases of septic loosening. Of all nine specified areas of glenoid, tip lucency on x-ray appeared to be most strongly associated with need for glenoid revision. 5/9 cases with tip lucency progressed to loosening of the glenoid. Where tip lucency was not seen, 93/96 glenoid components remained secure, giving tip lucency a negative predictive value of 97%. Excluding the two infected cases, the glenoid remained secure in 97/103 patients undergoing BW-TSR with follow-up up to 13 years. The BW-TSR is a satisfactory and durable solution to the cuff-deficient shoulder in variety of challenging groups including younger patients and as a salvage procedure following failed, cuff-deficient arthroplasty.


Orthopaedic Proceedings
Vol. 93-B, Issue SUPP_I | Pages 52 - 53
1 Jan 2011
Griffiths D Templeton-Ward O Grange S Lambert S Bayley I Falworth M
Full Access

Arthroplasty as a salvage procedure for cuff and glenoid deficiency poses major problems due to the limitations in treatment options and debilitating symptoms. We hypothesized that computer aided deigned and manufactured (CADCAM) total shoulder arthroplasty, using a precisely fitted glenoid shell, can relieve the pain and poor function associated with irreparable rotator cuff pathology and severe glenoid deficiency in the shoulder.

Of the 127 cases so far performed, a prospective cohort study 79 consecutive subjects, with a mean 28.7 month follow-up, were evaluated by a single practitioner blinded to their group status. Outcome was assessed using a validated clinical shoulder scoring system and radiographic review.

The subjects had a mean age of 58 (41–82) and their indication (where recorded) was mainly revision total shoulder replacement (62%) with some cases for primary osteoarthritis (12%) and rheumatoid arthritis (9%) and a proportion for other reasons (19%) including 1 re-revision case for dislocation.

Clinical follow-up was limited in this population (n=58, 73%) The ‘CADCAM’ group’s mean Stanmore Percentage of Normal Shoulder Assessment scores (SPONSA) were relatively unchanged post surgery (47 to 42 p=0.3). The Oxford Shoulder scores improved significantly (15 to 33, p< 0.0001). Most significantly, and by way of explanation, post surgery subjects recorded a reduction in the Visual Analogue Scale (Pain) scores (6.6 to 2.9) p< 0.0001). Patient satisfaction was generally good.

Radiographic review of the 79 cases revealed glenoid component screw breakage (4%, n=5) which is a moderate correlate of glenoid loosening (r = 0.65, r2 = 0.42) and probably more accurate than radiographic lucent lines seen in 6% (n=7). Humeral lucency was seen in 10%, (n=8). These radiographic findings correlated well with the clinical findings.

Postoperative pain and function was significantly improved in subjects undergoing the ‘CADCAM’ technique of shoulder arthroplasty offering a consistent salvage option for situations where no alternative to glenoid reconstruction is feasible.